Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, provides trial evidence showing that patients may not benefit from high dose chest radiation therapy vs. standard dose therapy.
Advertisement
High vs. Standard Dose Chest Radiation in Stage III Lung Cancer [720p]
